Found 7 matching trials
A Study to Test Once-Weekly Doses of Odanacatib (MK0822) on Healthy Adult Females (0822-005)(COMPLETED)
PHASE1This study will assess the safety, tolerability, PK, and PD of a once weekl...
Location
Multiple Locations
Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Alendronate (MK-0822-050)
PHASE3This study will evaluate the therapeutic effects and safety of odanacatib o...
Location
Multiple Locations
Study of Multiple Oral Doses of Odanacatib (MK0822) in Healthy Adults (0822-002)
PHASE1This study will assess the safety, tolerability, pharmacokinetics, and phar...
Location
Multiple Locations
Safety and Tolerability of Odanacatib (0822-059)
PHASE1This study will test the weighted average inhibition of u-NTx/Cre (aminoter...
Location
Multiple Locations
A Study to Assess the Effects of a Light Breakfast on the Safety, Tolerability, and Pharmacokinetics of Odanacatib (MK0822)
PHASE1This study will assess the safety and tolerability of single doses of odana...
Location
Multiple Locations
A Single-Dose Study of the Safety, Tolerability, and Pharmacokinetics of Odanacatib (MK0822) in Healthy Volunteers
PHASE1This study assessed the safety, tolerability, and pharmacokinetics of singl...
Location
Multiple Locations
A Study to Assess the Effects of MK0822 in Reducing the Risk of Bone Metastasis in Women With Breast Cancer (0822-029)
PHASE3The purpose of this study is to test MK0822 on reducing the risk of bone me...
Location
Multiple Locations